Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer

• Main Authors: Vicharn Lorvidhaya, Imjai Chitapanarux, Pramook Phromratanapongse, Pimkhuan Kamnerdsupaphon, Ekkasit Tharavichitkul, Prasert Lertsanguansinchai, Chang Yao Hsieh, Vimol Sukthomya
• 格式: 雜誌
• 出版: 2018
• 主題: Biochemistry, Genetics and Molecular Biology; Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79961108269&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/50555
• 機構: Chiang Mai University

Purpose: The objective of this study is to evaluate the efficacy and safety of capecitabine in cervical cancer patients who have locoregional failure and/or distant metastasis and failed first line therapy. The efficacy of capecitabine is determined by the overall response rate (ORR) according to WH...